What is rabbit syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabbit Syndrome: Definition and Clinical Characteristics

Rabbit syndrome is a rare antipsychotic-induced extrapyramidal side effect characterized by rapid, fine, rhythmic vertical movements of the mouth and lips (approximately 5 Hz frequency) that resemble the chewing motions of a rabbit, with the critical distinguishing feature being the complete absence of tongue involvement. 1

Key Diagnostic Features

  • Movement pattern: Vertical-only motion of the mouth/lips at about 5 Hz frequency, with no lateral or rotatory components 1, 2
  • Anatomical specificity: Affects only the buccal (mouth) region; tongue remains completely uninvolved, which is the critical distinguishing feature from tardive dyskinesia 1, 3
  • Appearance: The involuntary movements closely resemble the chewing and puckering motions of a rabbit 3

Epidemiology and Causative Agents

  • Prevalence: Ranges from 2.3% to 4.4% of patients treated with typical antipsychotics 1
  • Onset timing: Usually appears after prolonged antipsychotic treatment (months to years), though rare cases occur without antipsychotic exposure 1
  • Associated medications:
    • Primarily typical (first-generation) antipsychotics with long-term use 1
    • Atypical antipsychotics including risperidone 4, 3, clozapine 2, aripiprazole 5, and olanzapine 2

Critical Diagnostic Pitfall

The most common misdiagnosis is oral tardive dyskinesia. The key differentiating feature is that tardive dyskinesia involves tongue movements (lateral, rotatory, or protrusion), while rabbit syndrome has absolutely no tongue involvement—only vertical lip/mouth movements. 1

Pathophysiology

  • Neuroanatomical localization: The syndrome's extreme specificity to the buccal region with stereotyped movements implicates the basal ganglia, particularly the substantia nigra pars reticulata 1
  • Mechanism: Likely related to dopamine-serotonin interactions, as evidenced by withdrawal-emergent cases during risperidone dose reduction 4
  • Classification: Considered an extrapyramidal side effect based on rapid response to anticholinergic medication 3

Treatment Algorithm

Step 1: Reduce antipsychotic dosage as much as clinically feasible 1

Step 2: If full withdrawal is impossible (most cases), initiate anticholinergic therapy:

  • Trihexyphenidyl is the first-line treatment and typically produces rapid symptom control 4, 1
  • Anticholinergic drugs are the best-known and most effective treatment 1

Step 3: Do NOT use levodopa or dopamine agonists—rabbit syndrome does not respond to these agents 1

Special Considerations

  • Withdrawal-emergent cases: Can occur during dose reduction of atypical antipsychotics, particularly risperidone, suggesting serotonergic system involvement 4
  • Atypical antipsychotics: Despite lower overall extrapyramidal side effect profiles, aripiprazole, risperidone, clozapine, and olanzapine can all cause rabbit syndrome, requiring vigilant monitoring 2, 5
  • D2 receptor occupancy: Even atypical agents with partial D2 agonism (like aripiprazole) can induce the syndrome, emphasizing the need for caution regardless of the antipsychotic's pharmacological profile 5

References

Research

Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999

Research

Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001

Research

Aripiprazole-induced rabbit syndrome: a case report.

Journal of psychopharmacology (Oxford, England), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.